Ranbaxy to exit Japanese JV with Nippon Chemiphar

Ranbaxy Laboratories plans to exit its Japanese joint venture -- Nihon Pharmaceuticals Industry -- by selling its 50 per cent stake after the Indian drug maker was acquired by Japanese drug major......